{"id":"559434-1066","orgnr":"559434-1066","name":"Qualipharma AB","name_registered_on":"2023-05-15","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2023-05-15","business_description":"Företaget ska arbeta med att stötta apotek och läkemedelsföretag via projektledning och kunskap inom regulatory affairs i form av konsultuppdrag.","industries":[{"code":"47731","name":"Detaljhandel med apoteksvaror, utom via internet eller postorder"}],"postal_address":{"street":"Vitmåravägen 87","postal_code":"19460","city":"UPPLANDS VÄSBY","country":"SE","municipality":{"code":"0114","name":"Upplands Väsby"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0114","name":"Upplands Väsby"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"2","name":"500 - 999 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2023-05-15","to":"2024-04-30","framework":"K2","signed_on":"2024-05-14","documents":{"annual_report":"/v1/documents/613abdf5-7714-4a9f-915d-85f943e1c58e.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/24_8.zip"}}],"latest_financials":{"from":"2023-05-15","to":"2024-04-30","scope":"company","currency":"SEK","net_sales":159637,"operating_profit":146209,"profit_after_financial_items":146278,"net_profit":86858,"total_assets":210819,"current_assets":210819,"equity":111858,"share_capital":25000,"unrestricted_equity":86858,"untaxed_reserves":36725,"current_liabilities":62236,"tax_liabilities":22695,"cash":122663,"staff_costs":7011,"employees":1,"equity_ratio":0.669,"source":{"annual_report":"2024-04-30","document":"/v1/documents/613abdf5-7714-4a9f-915d-85f943e1c58e.xhtml"},"anchors":{"cash":{"text":"122 663","suffix":"Summa omsättningstillgångar"},"current_assets":{"text":"210 819","prefix":"omsättningstillgångar"},"current_liabilities":{"text":"62 236"},"employees":{"text":"1","suffix":"Förändringar"},"equity":{"text":"111 858"},"equity_ratio":{"text":"66,9"},"net_profit":{"text":"86 858","prefix":"resultat","suffix":"Qualipharma"},"net_sales":{"text":"159 637","suffix":"Resultat"},"operating_profit":{"text":"146 209","suffix":"Balansomslutning"},"profit_after_financial_items":{"text":"146 278","suffix":"Soliditet"},"share_capital":{"text":"25 000","prefix":"utgång"},"staff_costs":{"text":"7 011"},"tax_liabilities":{"text":"22 695","prefix":"Skatteskulder"},"total_assets":{"text":"210 819","prefix":"Balansomslutning"},"unrestricted_equity":{"text":"86 858","suffix":"Styrelsen"},"untaxed_reserves":{"text":"36 725","prefix":"reserver"}}},"officers":{"annual_report":"2024-04-30","signed_on":"2024-05-14","signatories":[{"name":"N*****","role":"Verkställande direktör"},{"name":"B*****","role":"Styrelsesuppleant"}]}}